Server:Apache...
The main IP address: 174.129.25.170,Your server United States,Ashburn ISP:Amazon.com Inc. TLD:uk CountryCode:US
The description :our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. with our portfolio of respiratory products we’re making good progress towards achie...
This report updates in 29-Nov-2018
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host circassia.co.uk. Currently, hosted in United States and its service provider is Amazon.com Inc. .
Latitude: | 39.043720245361 |
Longitude: | -77.487487792969 |
Country: | United States (US) |
City: | Ashburn |
Region: | Virginia |
ISP: | Amazon.com Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Transfer-Encoding: | chunked |
Server: | Apache |
Connection: | close |
Link: | |
Date: | Thu, 29 Nov 2018 02:18:35 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns.123-reg.co.uk. hostmaster.circassia.co.uk. 2015040202 14400 0 604800 14400 |
txt: | "AAgzuhqEaRhEfbDZF8hQdZyKbUmnpF3lUxdQwQbTeFZsnOADXGLFHiA/De2IpPqiaXrVuJuGIFePQ9XWEOX5ZA==" "MS=ms99552237" "v=spf1 include:spf.protection.outlook.com ip4:62.232.37.242/31 -all" "google-site-verification=G9YxZcvWY0hhl7S-V08ovk2tJTALLpvHVCtyWDY60Y0" |
ns: | ns2.123-reg.co.uk. ns.123-reg.co.uk. |
ipv4: | IP:174.129.25.170 ASN:14618 OWNER:AMAZON-AES - Amazon.com, Inc., US Country:US |
mx: | MX preference = 1, mail exchanger = circassia-co-uk.mail.protection.outlook.com. |
skip to main content toggle search search toggle navigation home company about us board of directors management team corporate responsibility technologies circassia technologies particle-engineered respiratory therapies our proprietary particle-engineering technologies underpin a portfolio of respiratory product candidates for which we are seeking development partners. niox® feno testing our niox® products accurately measure the concentration of fractional exhaled nitric oxide (feno) in asthma patients’ breath to help evaluate underlying airway inflammation. technologies products pipeline pipeline products asthma therapies flixotide® / flovent® substitute seretide® substitute copd treatments duaklir® us spiriva® substitute novel laba / lama formulation & novel copd therapy formulation pipeline chart commercial opportunity investors regulatory news share price summary share price chart analyst coverage financial reports financial calendar registrars corporate governance warning to shareholders email alerts investor contacts historic transactions careers career opportunities uk opportunities us opportunities european opportunities china opportunities opportunities job applicant privacy notice careers contacts media latest press release interim results for the six months ended 30 june 2018 27th september 2018 press releases presentations webcasts & audio image library media contacts contacts locations departments conferences a world-class specialty pharmaceutical company our ambition is to become a leading specialty pharmaceutical company meeting the needs of patients around the world. with our portfolio of respiratory products we’re making good progress towards achieving our goal. our technologies our proprietary technologies are designed to develop a range of therapies for asthma and chronic obstructive pulmonary disease (copd). our products our novel niox® products are used to help improve asthma management around the world, and we market the copd therapy tudorza® in the united states. our pipeline we have a broad range of respiratory product candidates for which we are seeking development partners. about us we’re a world-class specialty pharmaceutical company focused on asthma and copd. careers we’re a rapidly growing company with a range of exciting career opportunities. investors circassia is listed on the london stock exchange under the ticker cir. press releases interim results for the six months ended 30 june 2018 27th september 2018 circassia announces duaklir® new drug application (nda) and tudorza® supplemental nda accepted for review by fda 13th august 2018 circassia announces submission of duaklir® new drug application and tudorza® supplemental new drug application in the united states 1st june 2018 more press releases share price full share price chart annual report read the annual report (pdf) © 2018 circassia. all rights reserved. legal notice privacy policy privacy shield policy cookie settings site map
https://www.circassia.com/careers/opportunities/
https://www.circassia.com/contacts/
https://www.circassia.com/careers/region/european-opportunities/
https://www.circassia.com/technologies/tech/niox-feno-testing/
https://www.circassia.com/investors/financial-calendar/
https://www.circassia.com/company/corporate-responsibility/
https://www.circassia.com/media/media-contacts/
https://www.circassia.com/privacy/
https://www.circassia.com/careers/
https://www.circassia.com/site-map/
https://www.circassia.com/investors/
https://www.circassia.com/media/webcasts-audio/
https://www.circassia.com/products/
https://www.circassia.com/investors/registrars/
https://www.circassia.com/investors/investor-contacts/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Error for "circassia.co.uk".
the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 227 seconds
WHOIS lookup made at 06:58:40 24-Sep-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS circassia.co.uk
PORT 43
TYPE domain
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
DOMAIN
NAME circassia.co.uk
NSERVER
NS.123-REG.CO.UK 212.67.202.2
NS2.123-REG.CO.UK 62.138.132.21
The following list shows you to spelling mistakes possible of the internet users for the website searched .